AI Verdict
VRTX has stronger fundamentals based on our AI analysis.
ELV vs VRTX Fundamental Comparison
| Metric | ELV | VRTX |
|---|---|---|
| Revenue | $50.2B | $3.0B |
| Net Income | $1.8B | $1.0B |
| Net Margin | 3.5% | 34.5% |
| ROE | 4.0% | 5.3% |
| ROA | 1.4% | 3.9% |
| Current Ratio | 1.48x | 3.02x |
| Debt/Equity | 0.71x | 0.01x |
| EPS | $8.00 | $4.02 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ELV vs VRTX: Frequently Asked Questions
Is ELV or VRTX the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), VRTX has stronger fundamentals. ELV is graded B (76% confidence) while VRTX is graded A (81% confidence). This is not investment advice.
How does ELV compare to VRTX fundamentally?
Elevance Health, Inc. has ROE of 4.0% vs VERTEX PHARMACEUTICALS INC / MA's 5.3%. Net margins are 3.5% vs 34.5% respectively.
Which stock pays higher dividends, ELV or VRTX?
ELV has a dividend yield of N/A or no dividend while VRTX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ELV or VRTX for long term?
For long-term investing, consider that ELV has a B grade with 76% confidence, while VRTX has a A grade with 81% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ELV vs VRTX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ELV vs VRTX, the AI consensus favors VRTX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.